Fludarabine in the treatment of chronic lymphocytic leukemia: a review

Por Ricci, Francesca, Tedeschi, Alessandra, Morra, Enrica, Montillo, Marco
Publicado em 2009

Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom’s Macroglobulinemia

Por Ricci, Francesca, Tedeschi, Alessandra, Montillo, Marco, Morra, Enrica
Publicado em 2011

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)

Por Montillo, Marco, Ricci, Francesca, Miqueleiz, Sara, Tedeschi, Alessandra, Morra, Enrica
Publicado em 2008

The spectrum of use of rituximab in chronic lymphocytic leukemia

Por Tedeschi, Alessandra, Vismara, Eleonora, Ricci, Francesca, Morra, Enrica, Montillo, Marco
Publicado em 2010

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia

Por Frustaci, Anna Maria, Tedeschi, Alessandra, Picardi, Paola, Cairoli, Roberto, Montillo, Marco
Publicado no Biologics (2015)

Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association dat...

Por Frustaci, Anna Maria, Tedeschi, Alessandra, Picardi, Paola, Mazzucchelli, Maddalena, Cairoli, Roberto, Montillo, Marco
Publicado no Ther Adv Hematol (2016)

Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia

Por Montagna, Michela, Montillo, Marco, Avanzini, Maria A., Tinelli, Carmine, Tedeschi, Alessandra, Visai, Livia, Ricci, Francesca, Vismara, Eleonora, Morra, Enrica, Regazzi, Mario
Publicado em 2011

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic...

Por Bulian, Pietro, Rossi, Davide, Forconi, Francesco, Del Poeta, Giovanni, Bertoni, Francesco, Zucca, Emanuele, Montillo, Marco, Pozzato, Gabriele, D'Arena, Giovanni, Efremov, Dimitar G, Marasca, Roberto, Lauria, Francesco, Gaidano, Gianluca, Gattei, Valter, Laurenti, Luca
Publicado em 2012

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

Por Montillo, Marco, Tedeschi, Alessandra, Gaidano, Gianluca, Coscia, Marta, Petrizzi, Valeria Belsito, Orlandi, Ester, Cascavilla, Nicola, Ghia, Paolo, Motta, Marina, Gallamini, Andrea, Frustaci, Anna Maria, Rossi, Davide, De Paoli, Lorenzo, Nichelatti, Michele, Morra, Enrica, Massaia, Massimo
Publicado no Haematologica (2014)

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients

Por Tedeschi, Alessandra, Rossi, Davide, Motta, Marina, Quaresmini, Giulia, Rossi, Marianna, Coscia, Marta, Anastasia, Antonella, Rossini, Fausto, Cortelezzi, Agostino, Nador, Guido, Scarfò, Lydia, Cairoli, Roberto, Frustaci, Anna Maria, Dalceggio, Daniela, Picardi, Paola, De Paoli, Lorenzo, Orlandi, Ester, Rambaldi, Alessandro, Massaia, Massimo, Gaidano, Gianluca, Montillo, Marco
Publicado no Haematologica (2015)

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

Por Moreno, Carol, Montillo, Marco, Panayiotidis, Panayiotis, Dimou, Maria, Bloor, Adrian, Dupuis, Jehan, Schuh, Anna, Norin, Stefan, Geisler, Christian, Hillmen, Peter, Doubek, Michael, Trněný, Marek, Obrtlikova, Petra, Laurenti, Luca, Stilgenbauer, Stephan, Smolej, Lukas, Ghia, Paolo, Cymbalista, Florence, Jaeger, Ulrich, Stamatopoulos, Kostas, Stavroyianni, Niki, Carrington, Patrick, Zouabi, Hamadi, Leblond, Veronique, Gomez-Garcia, Juan C., Rubio, Martin, Marasca, Roberto, Musuraca, Gerardo, Rigacci, Luigi, Farina, Lucia, Paolini, Rossella, Pospisilova, Sarka, Kimby, Eva, Bradley, Colm, Montserrat, Emili
Publicado no Haematologica (2015)

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Por Rossi, Davide, Terzi-di-Bergamo, Lodovico, De Paoli, Lorenzo, Cerri, Michaela, Ghilardi, Guido, Chiarenza, Annalisa, Bulian, Pietro, Visco, Carlo, Mauro, Francesca R., Morabito, Fortunato, Cortelezzi, Agostino, Zaja, Francesco, Forconi, Francesco, Laurenti, Luca, Del Giudice, Ilaria, Gentile, Massimo, Vincelli, Iolanda, Motta, Marina, Coscia, Marta, Rigolin, Gian Matteo, Tedeschi, Alessandra, Neri, Antonino, Marasca, Roberto, Perbellini, Omar, Moreno, Carol, Del Poeta, Giovanni, Massaia, Massimo, Zinzani, Pier Luigi, Montillo, Marco, Cuneo, Antonio, Gattei, Valter, Foà, Robin, Gaidano, Gianluca
Publicado no Blood (2015)

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Por Baliakas, Panagiotis, Agathangelidis, Andreas, Hadzidimitriou, Anastasia, Sutton, Lesley-Ann, Minga, Eva, Tsanousa, Athina, Scarfò, Lydia, Davis, Zadie, Yan, Xiao-Jie, Shanafelt, Tait, Plevova, Karla, Sandberg, Yorick, Vojdeman, Fie Juhl, Boudjogra, Myriam, Tzenou, Tatiana, Chatzouli, Maria, Chu, Charles C., Veronese, Silvio, Gardiner, Anne, Mansouri, Larry, Smedby, Karin E., Pedersen, Lone Bredo, Moreno, Denis, Van Lom, Kirsten, Giudicelli, Véronique, Francova, Hana Skuhrova, Nguyen-Khac, Florence, Panagiotidis, Panagiotis, Juliusson, Gunnar, Angelis, Lefteris, Anagnostopoulos, Achilles, Lefranc, Marie-Paule, Facco, Monica, Trentin, Livio, Catherwood, Mark, Montillo, Marco, Geisler, Christian H., Langerak, Anton W., Pospisilova, Sarka, Chiorazzi, Nicholas, Oscier, David, Jelinek, Diane F., Darzentas, Nikos, Belessi, Chrysoula, Davi, Frederic, Ghia, Paolo, Rosenquist, Richard, Stamatopoulos, Kostas
Publicado no Blood (2015)